LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
37.83
-3.08 (-7.53%)
At close: Aug 15, 2025, 3:59 PM
39.27
3.81%
After-hours: Aug 15, 2025, 07:32 PM EDT

LENZ Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-14.91M -14.62M -12.65M -10.21M -10.25M -16.65M -23.69M -22.48M -55.31M -23.93M -24.6M -24.68M -26.66M -26.14M -18.93M -14.59M -17.53M -19.71M
Depreciation & Amortization
19K 36K 25K 10K 18K 5K 4K 800K 2.1M 2.22M 2.22M 2.17M 2.06M 1.89M n/a 556K 100K 90K
Stock-Based Compensation
2.85M 2.56M 1.63M 2.19M 1.6M 947K 518K 494K 189K 142K 377K n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
2.29M -2.2M 2.01M 436K -3.51M -7.74M 1.89M 623K 1.99M -470K -1.47M -2.74M -1.92M -1.27M -1.25M -1.42M -1.76M 102K
Other Non-Cash Items
-888K -1.05M -1.41M -1.36M -959K 772K -780K 8.79M 42.77M 6.73M 8.03M 6.59M 7.95M 6.9M 3.17M 5.82M -1.13M 11.37M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
1.43M -2.97M 3.33M -1.21M -6.2M -9.01M 2.98M 2.86M 1.49M -1.06M -2.55M -2.35M -1.62M -684K -543K -3.75M 1.61M 185K
Operating Cash Flow
-11.51M -16.05M -9.08M -10.58M -15.79M -23.94M -20.97M -9.4M -13.65M -21.07M -22.43M -22.22M -22.09M -21.24M -15.59M -15.41M -13.78M -8.06M
Capital Expenditures
-240K -110K -149K -186K -133K n/a n/a -4.81M -5.61M -383K -1.02M -915K -1.39M -3.27M -981K -3.64M -763K -360K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 679K 888K 337K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-58.29M -33.09M -46.61M -84.04M n/a n/a 1K -19.41M -1K -28.13M -65.7M -85.59M -86.83M -167.39M n/a n/a n/a n/a
Sales Maturities Of Investments
58.12M 52.09M 34.9M 22M 13M 18M 46.45M 67.8M 77.5M 71.67M 80.25M 90M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -111.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-414K 18.89M -11.86M -62.23M -98.39M 18M 47.08M 63.88M 72.23M 43.16M 13.52M 3.5M -88.22M -170.67M -981K -3.64M -763K -360K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -8K -51K -8K n/a -79K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
421K n/a 138K -13K 1.43M 117.88M n/a -576K n/a n/a n/a n/a n/a n/a 306K n/a n/a n/a
Financial Cash Flow
26.49M 44K 53K 29.82M -2.14M 171.27M 66K 8K 124K -8K 244K -59K 412K n/a 313K 31.89M 219.5M 165.77M
Net Cash Flow
14.57M 2.88M -20.89M -42.99M -116.32M 165.33M 2.87M 54.48M 58.7M 22.08M -8.66M -18.78M -109.9M -191.91M -17.98M 12.84M 204.95M n/a
Free Cash Flow
-11.75M -16.16M -9.23M -10.77M -15.93M -23.94M -20.97M -14.21M -19.27M -21.46M -23.45M -23.13M -23.48M -24.51M -16.57M -19.05M -14.55M -8.42M